High-dose Erythropoietin for Asphyxia and Encephalopathy
Public ClinicalTrials.gov record NCT02811263. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT02811263
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- University of California, San Francisco
- Other
- Enrollment
- 500 participants
Conditions and interventions
Conditions
Interventions
- Erythropoietin Drug
- Normal saline placebo Drug
Drug
Eligibility (public fields only)
- Age range
- Up to 24 Hours
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2016
- Primary completion
- Sep 30, 2021
- Completion
- Mar 31, 2022
- Last update posted
- Jan 29, 2023
2017 – 2022
United States locations
- U.S. sites
- 23
- U.S. states
- 11
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Children's Hospital Los Angeles | Los Angeles | California | — | — |
| Stanford University | Palo Alto | California | — | — |
| University of California, San Francisco | San Francisco | California | 94158 | — |
| Children's National Medical Center | Washington D.C. | District of Columbia | 20010 | — |
| Indiana University | Indianapolis | Indiana | — | — |
| Children's Hospitals and Clinics of Minnesota: Minneapolis | Minneapolis | Minnesota | — | — |
| Children's Hospitals and Clinics of Minnesota: St. Paul | Saint Paul | Minnesota | — | — |
| Washington University | St Louis | Missouri | 63110 | — |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | — | — |
| Good Samaritan Hospital | Cincinnati | Ohio | — | — |
| Nationwide Children's Hospital | Columbus | Ohio | — | — |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | — | — |
| Children's Hospital of Pittsburgh of UPMC | Pittsburgh | Pennsylvania | — | — |
| Magee Women's Hospital of UPMC | Pittsburgh | Pennsylvania | — | — |
| Vanderbilt University | Nashville | Tennessee | — | — |
| UT Southwestern | Dallas | Texas | — | — |
| Cook Children's Hospital | Fort Worth | Texas | — | — |
| Children's Hospital of San Antonio | San Antonio | Texas | — | — |
| Methodist Children's Hospital | San Antonio | Texas | — | — |
| Primary Children's Hospital | Salt Lake City | Utah | — | — |
| University of Utah | Salt Lake City | Utah | — | — |
| Seattle Children's Hospital | Seattle | Washington | 98105 | — |
| University of Washington Medical Center | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02811263, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 29, 2023 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02811263 live on ClinicalTrials.gov.